X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Novartis - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs NOVARTIS - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA NOVARTIS SANOFI INDIA/
NOVARTIS
 
P/E (TTM) x 29.7 343.1 8.7% View Chart
P/BV x 5.3 16.9 31.1% View Chart
Dividend Yield % 1.7 1.7 100.6%  

Financials

 SANOFI INDIA   NOVARTIS
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
NOVARTIS
Mar-16
SANOFI INDIA/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs4,560982 464.4%   
Low Rs4,400556 791.1%   
Sales per share (Unadj.) Rs1,028.5252.9 406.7%  
Earnings per share (Unadj.) Rs129.062.1 207.5%  
Cash flow per share (Unadj.) Rs186.063.3 293.8%  
Dividends per share (Unadj.) Rs68.0010.00 680.0%  
Dividend yield (eoy) %1.51.3 116.7%  
Book value per share (Unadj.) Rs753.6363.6 207.3%  
Shares outstanding (eoy) m23.0331.96 72.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.43.0 143.2%   
Avg P/E ratio x34.712.4 280.7%  
P/CF ratio (eoy) x24.112.2 198.2%  
Price / Book Value ratio x5.92.1 281.1%  
Dividend payout %52.716.1 327.7%   
Avg Mkt Cap Rs m103,17424,580 419.7%   
No. of employees `0003.60.8 481.8%   
Total wages/salary Rs m3,5921,801 199.4%   
Avg. sales/employee Rs Th6,537.710,748.9 60.8%   
Avg. wages/employee Rs Th991.42,395.2 41.4%   
Avg. net profit/employee Rs Th819.82,641.1 31.0%   
INCOME DATA
Net Sales Rs m23,6868,083 293.0%  
Other income Rs m708829 85.4%   
Total revenues Rs m24,3948,913 273.7%   
Gross profit Rs m5,281234 2,254.9%  
Depreciation Rs m1,31337 3,577.7%   
Interest Rs m152 833.3%   
Profit before tax Rs m4,6611,025 454.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m017 0.0%   
Extraordinary Inc (Exp) Rs m01,696 0.0%   
Tax Rs m1,691752 224.9%   
Profit after tax Rs m2,9701,986 149.5%  
Gross profit margin %22.32.9 769.5%  
Effective tax rate %36.373.4 49.5%   
Net profit margin %12.524.6 51.0%  
BALANCE SHEET DATA
Current assets Rs m15,67312,678 123.6%   
Current liabilities Rs m6,6782,433 274.5%   
Net working cap to sales %38.0126.7 30.0%  
Current ratio x2.35.2 45.0%  
Inventory Days Days7633 232.4%  
Debtors Days Days2222 99.2%  
Net fixed assets Rs m8,09869 11,702.3%   
Share capital Rs m230160 144.1%   
"Free" reserves Rs m17,08811,460 149.1%   
Net worth Rs m17,35611,621 149.3%   
Long term debt Rs m00-   
Total assets Rs m25,40014,400 176.4%  
Interest coverage x311.7570.5 54.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.6 166.1%   
Return on assets %11.813.8 85.1%  
Return on equity %17.117.1 100.1%  
Return on capital %26.923.6 114.3%  
Exports to sales %24.50.7 3,288.5%   
Imports to sales %28.018.6 150.5%   
Exports (fob) Rs m5,80160 9,636.2%   
Imports (cif) Rs m6,6271,503 441.0%   
Fx inflow Rs m7,145186 3,835.2%   
Fx outflow Rs m6,8461,821 376.0%   
Net fx Rs m299-1,635 -18.3%   
CASH FLOW
From Operations Rs m3,2262,531 127.5%  
From Investments Rs m-1,555-8,270 18.8%  
From Financial Activity Rs m-1,818-386 471.4%  
Net Cashflow Rs m-147-6,125 2.4%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 75.0 80.5%  
Indian inst/Mut Fund % 14.4 2.0 720.0%  
FIIs % 14.6 1.6 912.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 21.5 48.8%  
Shareholders   15,184 41,647 36.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   DIVIS LABORATORIES  WOCKHARDT LTD.  VENUS REMEDIES  PLETHICO PHARMA  GLENMARK PHARMA  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Aug 22, 2017 03:36 PM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 5-YR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS